Literature DB >> 33025796

Organizational Costs and Benefits of a Health System Quality Improvement Intervention to Increase Aspirin Use for Primary Prevention of Heart Attack and Stroke.

Jean Marie Abraham1, Niki Oldenburg, Milton Eder, Russell Luepker.   

Abstract

Performance improvement on clinical quality outcomes typically requires significant effort by personnel in health care organizations. Understanding the cost of quality improvement is important given diffusion of value-based contracting. This study investigates the organizational costs and benefits associated with planning and implementing the Ask about Aspirin intervention to increase use of low-dose aspirin in clinically recommended patient populations. Data from 4 health systems in Minnesota were used to estimate personnel effort and labor resource costs as well as corresponding benefits, measured as the change in aspirin use among eligible candidates during the study period. Overall personnel effort across the 4 systems was approximately 3900 hours with corresponding resource costs estimated to be $214,385. Aspirin use increased 4.7% overall, corresponding to roughly 1530 new users in the aspirin candidate population. Significant variation was observed by system in total hours reported, distribution of effort by activity type, and in benefits realized from the intervention.
Copyright © 2021 The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33025796      PMCID: PMC8116822          DOI: 10.1177/1062860620962572

Source DB:  PubMed          Journal:  Am J Med Qual        ISSN: 1062-8606            Impact factor:   1.200


  12 in total

1.  Deaths preventable in the U.S. by improvements in use of clinical preventive services.

Authors:  Thomas A Farley; Mehul A Dalal; Farzad Mostashari; Thomas R Frieden
Journal:  Am J Prev Med       Date:  2010-06       Impact factor: 5.043

2.  The Costs of Participating in a Diabetes Quality Improvement Collaborative: Variation Among Five Clinics.

Authors:  Neha A Sathe; Robert S Nocon; Brenna Hughes; Monica E Peek; Marshall H Chin; Elbert S Huang
Journal:  Jt Comm J Qual Patient Saf       Date:  2016-01

3.  Practice transformation? Opportunities and costs for primary care practices.

Authors:  James M Gill; Bruce Bagley
Journal:  Ann Fam Med       Date:  2013 May-Jun       Impact factor: 5.166

4.  Cost to primary care practices of responding to payer requests for quality and performance data.

Authors:  Jacqueline R Halladay; Sally C Stearns; Thomas Wroth; Lynn Spragens; Sara Hofstetter; Sheryl Zimmerman; Philip D Sloane
Journal:  Ann Fam Med       Date:  2009 Nov-Dec       Impact factor: 5.166

5.  Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Paul Muntner; Alvaro Alonso; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Sandeep R Das; Francesca N Delling; Luc Djousse; Mitchell S V Elkind; Jane F Ferguson; Myriam Fornage; Lori Chaffin Jordan; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Tak W Kwan; Daniel T Lackland; Tené T Lewis; Judith H Lichtman; Chris T Longenecker; Matthew Shane Loop; Pamela L Lutsey; Seth S Martin; Kunihiro Matsushita; Andrew E Moran; Michael E Mussolino; Martin O'Flaherty; Ambarish Pandey; Amanda M Perak; Wayne D Rosamond; Gregory A Roth; Uchechukwu K A Sampson; Gary M Satou; Emily B Schroeder; Svati H Shah; Nicole L Spartano; Andrew Stokes; David L Tirschwell; Connie W Tsao; Mintu P Turakhia; Lisa B VanWagner; John T Wilkins; Sally S Wong; Salim S Virani
Journal:  Circulation       Date:  2019-03-05       Impact factor: 29.690

6.  A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Authors:  Paul M Ridker; Nancy R Cook; I-Min Lee; David Gordon; J Michael Gaziano; Joann E Manson; Charles H Hennekens; Julie E Buring
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

7.  Final report on the aspirin component of the ongoing Physicians' Health Study.

Authors: 
Journal:  N Engl J Med       Date:  1989-07-20       Impact factor: 91.245

8.  Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk.

Authors:  Jacoba P Greving; Erik Buskens; Hendrik Koffijberg; Ale Algra
Journal:  Circulation       Date:  2008-05-27       Impact factor: 29.690

9.  Cost-Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease.

Authors:  Tzeyu L Michaud; Jean Abraham; Hawre Jalal; Russell V Luepker; Sue Duval; Alan T Hirsch
Journal:  J Am Heart Assoc       Date:  2015-12-23       Impact factor: 5.501

10.  Population Trends in Aspirin Use for Cardiovascular Disease Prevention 1980-2009: The Minnesota Heart Survey.

Authors:  Russell V Luepker; Lyn M Steffen; Sue Duval; Nicole D Zantek; Xia Zhou; Alan T Hirsch
Journal:  J Am Heart Assoc       Date:  2015-12-23       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.